share this article!

Getty
Every day, Q.ai sends you a selection of hot stocks that have piqued the interest of hedge funds, individual investors, and the rare Robinhood user. And, in honor of the new month, today’s batch includes a very eclectic mix of products ranging from vaccines and bath towels to spirits and cloud computing. Without further ado, let’s take a look at what stocks are trending as we ring in the Fourth of July with a bang.
To gain the most up-to-date information on stocks and ETFs, Q.ai runs daily factor models. Our deep-learning algorithms use Artificial Intelligence (AI) technology to deliver a comprehensive, intelligence-based analysis of a company, so you don’t have to.
To join an exclusive AI investing community and receive premium investing ideas before markets open, sign up for the free Forbes AI Investor newsletter here.
Moderna, Inc. is a company that specializes in the design (MRNA)
Moderna, Inc jumped about 5.2 percent to $234.46 on Tuesday, with 11.4 million shares traded, well above the 22-day average of $208.91. The stock has gained 124.4 percent year to date, despite trading at only 8.5 times forecast earnings.
Moderna’s stock has been trending higher this week after a series of lab studies demonstrated that its innovative mRNA vaccine could protect against various coronavirus strains. The two-dose vaccine produced neutralizing antibodies against variants first detected in South Africa and Nigeria, as well as the highly contagious delta strain that first appeared in India. As a result of the news, Moderna’s shares hit fresh highs as of Tuesday’s close.
ADDITIONAL INFORMATION FOR YOU

Since its IPO in 2018, Moderna has performed well, according to Forbes AI Investor.

Moderna’s sales increased by 240 percent in the latest fiscal year – though that’s nothing compared to the 1,923 percent increase in the previous three – bringing total revenue from $135 million to $803 million. Operating income nearly doubled from $413 million to $763 million during the period, however per-share earnings fell to $1.96 from $4.95. Return on equity, on the other hand, has increased from 35.7 percent to little under 40 percent.
Moderna’s income is predicted to increase by roughly 17% during the following twelve months. Our deep-learning algorithms give this vaccine stock a B in Quality Value, a D in Technicals, a F in Growth, and a D in Low Volatility Momentum at this moment.
Bed Bath & Beyond (BBBY) fell 2.45% on Tuesday, finishing out 6 million trades at $29.91 per share. The stock is trading just over the 10-day price average, but well below the 22-day average by over a dollar. Despite this, the stock is up 68.4% year to date and trades at 21 times anticipated earnings.
The home goods giant Bed Bath & Beyond is trending this week in anticipation of – and reaction to – its first quarter 2021 earnings announcement. The company reported $1.95 billion in net sales, with core sales increasing 73 percent year over year and comparable sales up 86 percent year over year. CEO Mark Tritton also boosted the company’s full-year adjusted operating profit forecast from $500 million to $520-540 million.
This wonderful news, on the other hand, provided fodder for meme traders, who drove the stock up by more than 40% on June 2.

5-year performance of Bed Bath & Beyond
Forbes Investor in Artificial Intelligence
Aside from the memes, Bed Bath & Beyond had a decent fiscal year, with revenue up 7% to $9.23 billion, albeit the firm still has a long way to go to match its $12 billion revenue from three years ago. Operating income increased 1,105 percent to $35.9 million in the same 12-month period, but was still significantly behind the $422.8 million witnessed three years before.
However, per-share earnings increased from $1.02 to $1.24 over the 36-month period. Overall, return on equity was just under 10% in the last year, compared to 5% three years earlier. Bed Bath & Beyond now has a C in Technicals, Growth, and Quality Value, and a F in Low Volatility Momentum, according to our AI.
Constellation Brands, Inc (STZ) gained 0.7 percent on Tuesday, closing out 1.3 million shares at $230.98. The stock is trading in the middle of its 10- and 22-day price averages of $227.48 and $233.22. The stock is currently up 5.5 percent year to date and trades at 22.3 times anticipated earnings.
Constellation Brands is a Fortune 500 corporation that produces and markets a variety of beers, wines, and spirits in the United States, as well as being the largest beer importer by sales.
The company is rising this week after reporting $2 billion in net sales and $75 million in operating profits for the first quarter of 2022 on June 30, up 3% and 88 percent, respectively, from the previous quarter. The company’s board of directors also declared a quarterly cash dividend of $0.76 per share on Class A common stock and $0.69 per share on Class B common stock, which will be paid on August 24.

The 5-year performance of Constellation Brands
Forbes Investor in Artificial Intelligence
Despite its declining EPS, the company has generated positive cash flow over the last three years. For example, revenue increased by over 7% in the prior three fiscal years to $8.6 billion from $8.1 billion, while operating income increased by nearly 7% to $2.96 billion from $2.6 billion. In the same time period, however, per-share earnings have dropped from $17.57 to $10.32, and ROE has dropped from 33.2 percent to 15.4 percent.
Constellation Brands’ revenue growth is estimated to be roughly 0.7 percent over the next 12 months. This company receives a C in Growth, Low Volatility Momentum, and Quality Value, as well as a D in Technicals, from our AI.
Advanced Micro Devices, Inc (AMD) Advanced Micro Devices, Inc (AMD) gained 2.8 percent to $89.52 on Tuesday, with 46 million trades on the books at the end of the day. The stock was down 2.4 percent YTD and priced at 43.5 times anticipated earnings as of Tuesday’s closing, though its prospects improved slightly after Wednesday’s finish of over $94 per share.
The UK Competition and Markets Authority approved AMD’s merger with Xilinx this week, putting the business on our trending list. The examination, which began in May, found no problems to the combination, and the transaction was also passed over for comment by the US Federal Trade Commission, implying that American regulators found no outcomes that would break American rules.
The European Union and China, however, have yet to assess the agreement. AMD’s acquisition of Xilinx, if it goes through, will allow the rising chipmaker to expand its influence in telecommunications, defense, and aerospace, among other industries.

5-year performance of Advanced Micro Devices
Forbes Investor in Artificial Intelligence
AMD’s sales increased 76.4 percent to $9.76 billion in the last three fiscal years, up from $6.5 billion the previous year, while operating income increased 314 percent from $451 million to nearly $1.37 billion. Over the same three-year period, EPS increased by 644 percent, from 32 cents to $2.06, while ROE increased from 36 percent to 57.5 percent.
AMD’s revenue is predicted to expand by around 2.1 percent over the next 12 months. This investment currently receives an A in Growth, a C in Low Volatility Momentum and Quality Value, and a F in Technicals, according to our AI.
Salesforce.com, Inc (CRM) rose 0.5 percent on Tuesday to close at $245.81 per share, with 3.87 million trades. The stock has gained 10.5 percent this year and is currently trading at 67.5 times anticipated earnings.
As the cloud-based customer relationship management company nears its upcoming acquisition of Slack, Salesforce is trending widely. The $27.7 billion acquisition of the online chat service by the firm was initially reported in late 2020. The agreement is anticipated to finalize on July 31st, barring any unforeseen circumstances.
Salesforce is also in the news this week after completing a $8 billion bond offering on Tuesday. The 40-year security in the six-part offering is scheduled to yield 95 basis points more than Treasuries. Apart from financing the acquisition, the proceeds will be used to support sustainability initiatives, such as new or ongoing green and social projects on the company’s agenda.

Performance of Salesforce.com during a five-year period
Forbes Investor in Artificial Intelligence
Salesforce has grown its sales by 68.3 percent to $21.25 billion in the last three fiscal years, up from $13.28 billion three years ago. Operating income declined from $535 million to $455 million during the same time period, despite a significant increase of 108.6% in the previous fiscal year. Furthermore, per-share earnings increased by 231.7 percent in 36 months, from $1.43 to $4.38, while ROE increased to 10.8 percent.
Salesforce.com is now forecasting a 5% revenue increase over the next 12 months. At this time, our AI gives the company a C in Growth and Quality Value, a D in Low Volatility Momentum, and a F in Technicals.
Did you enjoy what you read? To receive monthly AI-driven investing ideas, sign up for our free Forbes AI Investor Newsletter. Subscribers can join an exclusive Slack channel for a short time to obtain these ideas before the markets open./nRead More

share this article!